Skip to content

Gout in the Hand, Wrist and Elbow

Upper-limb gout for the hand surgeon — presentation and mimics, imaging, treat-to-target medical management, and surgical indications for tophaceous complications.

Overview

Gout is the most common inflammatory arthritis, and although the first presentation is classically podagra, the upper limb is a frequent and sometimes initial site of disease. Tophaceous gout in the hand and wrist may present de novo as the first sign of the disease, particularly in the elderly, where it is readily mistaken for infection, rheumatoid or inflammatory arthritis, or a soft-tissue tumour [1]. For the upper-limb surgeon the condition matters on three fronts: it is a mimic that must be distinguished from sepsis and other arthritides; tophaceous deposits can compromise tendons, erode joints, ulcerate skin, and compress peripheral nerves [1]; and a hand sign of gout may be the presenting feature of an untreated systemic illness that warrants onward referral [4].

The cornerstone of treatment is medical — flare control plus treat-to-target urate-lowering therapy [8] — with surgery reserved for the mechanical and soft-tissue complications of longstanding tophaceous disease.

Background & Causes

Gout results from chronic hyperuricaemia and the deposition of monosodium urate (MSU) crystals in joints and periarticular soft tissue. Crystal-induced activation of the innate immune response drives the acute flare, while persistent deposition produces the chronic tophaceous burden. In the upper limb, deposits favour the digital and wrist joints and the extensor surfaces, and carpal bone involvement, although well described, occurs relatively late in the disease and is comparatively rarely reported [3].

Beyond the joints, urate can deposit within tendons and their sheaths. Gouty tenosynovitis is an under-recognised cause of upper-limb tendon dysfunction, and gout can both cause and simulate tendon rupture — including at sites as proximal as the distal biceps insertion — so it should be considered in a patient with a gout history and an atypical tendon presentation [5].

Symptoms & Presentation

The classic presentation is an acute, exquisitely painful monoarthritis with erythema and swelling; in the hand this is frequently confused with infection. Chronic disease presents with firm periarticular tophi, joint stiffness and deformity, and reduced hand function. The burden of tophaceous joint disease is a strong independent predictor of hand function in gout, underscoring the value of early urate control to preserve the hand [6].

Diagnosis rests on demonstration of MSU crystals, but imaging is increasingly useful: characteristic features include well-defined erosions with overhanging edges and sclerotic margins, and on advanced imaging the ultrasound "double-contour" sign and dual-energy CT urate mapping help confirm the diagnosis and quantify burden [7]. Because a hand finding can be the first clue to systemic disease, recognising these signs and referring appropriately is part of the hand surgeon's role [4].

Management

Acute flare. NSAIDs, colchicine and corticosteroids are all effective and broadly equivalent first-line options; selection is driven by comorbidity and interactions, and low-dose colchicine is preferred over high-dose [8]. The principles of medical management of acute gout are directly relevant to the hand surgeon who is often the first to see these patients [2].

Urate-lowering therapy (ULT). Definitive control is achieved with a treat-to-target strategy: allopurinol is first-line, started at low dose and titrated against serial serum urate to a target < 0.36 mmol/L (< 6 mg/dL), with anti-inflammatory prophylaxis for the first 3–6 months of titration [8]. ULT is indicated for tophaceous disease, radiographic joint damage, or frequent flares [8]. Sustained target urate dissolves crystal deposits and shrinks tophi over time.

Surgery. Operative treatment is reserved for the complications of tophaceous disease rather than the arthritis itself. Recognised indications include significant tendon or joint compromise, skin breakdown over ulcerating tophi, and decompression of compressive peripheral neuropathy; intervention ranges from simple aspiration or evacuation of liquid/pasty tophaceous material through to formal debulking, tenosynovectomy, joint procedures, and nerve decompression [1]. Medical urate-lowering must continue postoperatively.

Key Considerations

  • Never miss sepsis. Acute gout and septic arthritis are clinically indistinguishable in the hand and can coexist; aspirate and send fluid for both crystal analysis and culture before committing to a gout diagnosis.
  • Gout as a tendon-rupture mimic. Consider gouty tenosynovitis in a patient with a gout history presenting with atypical tendon pain or rupture, including proximal sites [5].
  • Preserve function early. Hand function tracks with tophaceous burden; the strongest lever is early, sustained urate control rather than surgery [6].
  • Perioperative urate control and wound healing. Optimise urate around elective surgery; skin and wound healing over tophaceous, often attenuated soft-tissue envelopes can be problematic, and debulking does not substitute for ongoing ULT.
  • Late carpal destruction. Chronic disease can involve the carpus and produce significant wrist destruction despite a relatively quiet early course [3].

Key Evidence

  • [L5] Tophaceous gout in the hand and wrist often presents de novo as the first sign of disease in the elderly; surgery is indicated for tendon and joint compromise, skin breakdown, and decompression of compressive neuropathy. (10.5435/00124635-200710000-00007)
  • [L1] Treat-to-target urate-lowering therapy with allopurinol first-line to a serum urate < 6 mg/dL, with flare prophylaxis during initiation, is strongly recommended; NSAIDs, colchicine and corticosteroids are first-line for the acute flare. (10.1002/acr.24180)
  • [L3] The burden of tophaceous joint disease strongly predicts hand function in patients with gout. (10.1093/rheumatology/kem246)
  • [L5] Carpal bone involvement in gout occurs relatively late in the disease and is rarely reported. (10.1007/s00402-007-0478-5)
  • [L5] Gout can cause and simulate upper-limb tendon rupture, including at the distal biceps insertion; consider it in patients with a gout history and atypical tendon presentations. (10.1177/1558944715627639)
  • [L5] Gouty arthropathy has characteristic clinico-pathologic and imaging features, including erosions with overhanging edges, the ultrasound double-contour sign, and dual-energy CT urate mapping. (10.1111/1754-9485.12356)
  • [L5] Hand surgeons should recognise signs of systemic illness in the hand and refer for appropriate work-up. (10.1016/j.jhsa.2025.06.019)

References

[1] Fitzgerald BT, Setty A, Mudgal CS. Gout affecting the hand and wrist. Journal of the American Academy of Orthopaedic Surgeons. 2007;15(10):625-35. DOI: 10.5435/00124635-200710000-00007

[2] Chimenti PC, Hammert WC. Medical management of acute gout. The Journal of Hand Surgery. 2012;37(10):2160-4. DOI: 10.1016/j.jhsa.2012.04.041

[3] Jerome JT, Sankaran B, Thirumagal K. Carpal bone involvement in gout. Archives of Orthopaedic and Trauma Surgery. 2007;127(10):971-4. DOI: 10.1007/s00402-007-0478-5

[4] Green A, Goitz RJ. Signs of systemic illness in the hand. The Journal of Hand Surgery. 2025;50(11):1381-91. DOI: 10.1016/j.jhsa.2025.06.019

[5] Fairhurst RJ, Schwartz AM, Rozmaryn LM. Gouty tenosynovitis of the distal biceps tendon insertion complicated by partial rupture. HAND. 2017;12(1):NP1-NP5. DOI: 10.1177/1558944715627639

[6] Dalbeth N, Collis J, Gregory K, et al. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford). 2007;46(12):1804-7. DOI: 10.1093/rheumatology/kem246

[7] Parathithasan N, Lee WK, Pianta M, et al. Gouty arthropathy: review of clinico-pathologic and imaging features. Journal of Medical Imaging and Radiation Oncology. 2016;60(1):9-20. DOI: 10.1111/1754-9485.12356

[8] FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care & Research. 2020;72(6):744-60. DOI: 10.1002/acr.24180

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International

Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees

Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.